All In Biotech

Drug Trial Radar · NCT07391605

Descartes-08 in Autoantibody Myositis

A Randomized Double-Blind Placebo-Controlled Study to Evaluate Efficacy, Safety, and Tolerability of Descartes-08 in Patients With Dermatomyositis and Antisynthetase Syndrome

Last checked: Nov 19, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Apr 28, 2026

Primary completion

Nov 2027

Study completion May 2028

Sponsor

Lead sponsor
Cartesian TherapeuticsIndustry
Sponsor type
Industry
First posted
Feb 6, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double-blind, placebo-controlled phase 2 study to evaluate the efficacy, safety and tolerability of an autologous T-cells expressing a chimeric antigen receptor (CAR) directed to B-Cell maturation antigen (BCMA) in patients with autoantibody-mediated myositis, including antisynthetase syndrome (ASyS) and dermatomyositis (DM).

Conditions

  • Antisynthetase Syndrome

Interventions

  • Descartes-08Drug

    Autologous T-cells expressing a chimeric antigen receptor (CAR) directed to B-Cell maturation antigen (BCMA)

  • PlaceboOther

    Plasma-Lyte

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Major improvement of 2016 ACR/EULAR Total Improvement scoreTime frame: 24 weeks

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • University of California, Irvine

    Orange, California · Recruiting

  • Brigham and Women's Hospital

    Boston, Massachusetts · Recruiting

  • University of North Carolina

    Chapel Hill, North Carolina · Recruiting

  • National Neuromuscular Research Institute

    Austin, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.